Metabolic disorders induced by salivary microbial imbalance can affect CD8+ T cell activity and PD‐L1 expression levels, a phenomenon closely associated with differential responses and resistance to immunotherapy in NSCLC patients, thereby providing a basis for developing personalized clinical immunotherapy regimens. The gene discussed is CD274; the disease is non-small cell lung carcinoma.